Publication: Effects Of Lactobacillus Spp. Against Vaginal Candidiasis In Pregnant Women
Date
2022-09
Authors
Ang, Xin Yee
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This study aimed to investigate the effects of lactobacilli probiotics in preventing the recurrences of vulvovaginal candidiasis (VVC) in 78 pregnant women with VVC (probiotic, n = 39; placebo, n = 39) and the potential benefits on quality of life. The lactobacilli probiotic (SynForU-HerCare; two capsules/day of 9.5 log CFU/capsule) or placebo was administered for 8-weeks in a randomized, double-blind, and placebo-controlled study. Subjects were assessed for vaginal and gut health conditions at week-0, 4, and 8 via questionnaires and analyzed vaginal microbiota and inflammatory changes. The vulvovaginal symptom questionnaire covered vulvovaginal symptoms and quality of life. Probiotic group was exhibited the reduction of irritation (P=0.023) and discharge (P=0.011) starting week-4 and continued after week-8 (P<0.05) as compared to the placebo. Probiotic group was exhibited the reduction of concern about symptoms after week-4 (P=0.010) and continued after week-8 (P=0.001), accompanied by reduced impairment of daily activities (P=0.012) and continued after week-8 (P=0.026). Probiotic group was exhibited the reduction of recurrences of both emotional and social stress compared to the placebo at both week-4 and week-8 (P<0.05). Probiotic group showed higher defecation times per week at week-4 (P=0.010) and week-8 (P=0.001) compared to the placebo group.
Description
Keywords
Effects Of Lactobacillus Spp. Against Vaginal , Candidiasis In Pregnant Women